RE:Q&A? Actually Q&A was done very well.
Overall take always :
Pouch is superior to competitors because it is retrievable unlike Semma. Peritoneal cavity has limitations . There is no vasualrization in pertioneal cavity . Dumping cells via portal vein has limitations not viable longterm .
conformal coding is proven to work in animal models including primates . Conformal coating works in stem cells as well as islets . Similar results to uncoated islet cells in releasing insulin.
No timeline for when conformal islets or stem cells will be uses in a Fd trial . Looks extremely positive to solve immunosuppresion issue . My take it will be a year at earliest to more likely longer as Bioteck alluded to .
Conformal coating will not provide any short term catalyst imo but longterm will be instrumental . Only short term catalyst for sp would be a collaborative deal which I personally do not think will materialize anytime soon possibly before year end, Sorry Charly .
MS